These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 30672316)
1. Protease-activated receptor 2 exacerbates cisplatin-induced nephrotoxicity. Watanabe M; Oe Y; Sato E; Sekimoto A; Sato H; Ito S; Takahashi N Am J Physiol Renal Physiol; 2019 Apr; 316(4):F654-F659. PubMed ID: 30672316 [TBL] [Abstract][Full Text] [Related]
2. Protease-activated receptor 2 exacerbates adenine-induced renal tubulointerstitial injury in mice. Hayashi S; Oe Y; Fushima T; Sato E; Sato H; Ito S; Takahashi N Biochem Biophys Res Commun; 2017 Jan; 483(1):547-552. PubMed ID: 28025140 [TBL] [Abstract][Full Text] [Related]
3. Asiatic acid protects against cisplatin-induced acute kidney injury via anti-apoptosis and anti-inflammation. Yang C; Guo Y; Huang TS; Zhao J; Huang XJ; Tang HX; An N; Pan Q; Xu YZ; Liu HF Biomed Pharmacother; 2018 Nov; 107():1354-1362. PubMed ID: 30257350 [TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation. Liang H; Liu HZ; Wang HB; Zhong JY; Yang CX; Zhang B Inflamm Res; 2017 May; 66(5):399-411. PubMed ID: 28224201 [TBL] [Abstract][Full Text] [Related]
5. The pathological role of Bax in cisplatin nephrotoxicity. Wei Q; Dong G; Franklin J; Dong Z Kidney Int; 2007 Jul; 72(1):53-62. PubMed ID: 17410096 [TBL] [Abstract][Full Text] [Related]
6. Glomerular Injury Is Exacerbated in Lupus-Prone MRL/lpr Mice Treated with a Protease-Activated Receptor 2 Antagonist. Itto R; Oe Y; Imaruoka K; Sato E; Sekimoto A; Yamakage S; Kumakura S; Sato H; Ito S; Takahashi N Tohoku J Exp Med; 2019 Oct; 249(2):127-133. PubMed ID: 31666446 [TBL] [Abstract][Full Text] [Related]
7. Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome. Redecha P; Franzke CW; Ruf W; Mackman N; Girardi G J Clin Invest; 2008 Oct; 118(10):3453-61. PubMed ID: 18802482 [TBL] [Abstract][Full Text] [Related]
8. IL-33 deficiency slows cancer growth but does not protect against cisplatin-induced AKI in mice with cancer. Ravichandran K; Holditch S; Brown CN; Wang Q; Ozkok A; Weiser-Evans MC; Nemenoff R; Miyazaki M; Thiessen-Philbrook H; Parikh CR; Ljubanovic D; Edelstein CL Am J Physiol Renal Physiol; 2018 Mar; 314(3):F356-F366. PubMed ID: 29070568 [TBL] [Abstract][Full Text] [Related]
9. CXCL16 regulates cisplatin-induced acute kidney injury. Liang H; Zhang Z; He L; Wang Y Oncotarget; 2016 May; 7(22):31652-62. PubMed ID: 27191747 [TBL] [Abstract][Full Text] [Related]
10. Activation of GSDMD contributes to acute kidney injury induced by cisplatin. Li Y; Xia W; Wu M; Yin J; Wang Q; Li S; Zhang A; Huang S; Zhang Y; Jia Z Am J Physiol Renal Physiol; 2020 Jan; 318(1):F96-F106. PubMed ID: 31682173 [TBL] [Abstract][Full Text] [Related]
11. The leukotriene B Deng B; Lin Y; Ma S; Zheng Y; Yang X; Li B; Yu W; Xu Q; Liu T; Hao C; He R; Ding F Kidney Int; 2017 Jul; 92(1):89-100. PubMed ID: 28318626 [TBL] [Abstract][Full Text] [Related]
12. LIGHT deficiency aggravates cisplatin-induced acute kidney injury by upregulating mitochondrial apoptosis. Yang Y; Meng L; Wu S; Li Y; Zhong Y; Xu F; Zhou XC; Li GQ; Xu GL; Peng KF Int Immunopharmacol; 2020 Dec; 89(Pt A):106999. PubMed ID: 33045563 [TBL] [Abstract][Full Text] [Related]
13. Dual blockade of protease-activated receptor 1 and 2 additively ameliorates diabetic kidney disease. Mitsui S; Oe Y; Sekimoto A; Sato E; Hashizume Y; Yamakage S; Kumakura S; Sato H; Ito S; Takahashi N Am J Physiol Renal Physiol; 2020 May; 318(5):F1067-F1073. PubMed ID: 32200667 [TBL] [Abstract][Full Text] [Related]